HOLOGIC INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows in 2025. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2025-10-20: Reporting owner Stamoulis Christiana; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2025-09-22: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2025-05-02: Reporting owner Liddy Anne M.; Form 3; Security Non-qualified Stock Option (Right to Buy); Transaction Holding.
- 2025-05-02: Reporting owner Liddy Anne M.; Form 3; Security Non-qualified Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-10-20 | Stamoulis Christiana Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,402 0 owned after | $36.04 exercise price | 2025-10-22 | |
| 2025-09-22 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −138,358 0 owned after | $39.96 exercise price | 2025-09-23 | |
| 2025-05-02 holding as of filing | Liddy Anne M. Officer (General Counsel) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $45.61 exercise price | 2025-05-02 | ||
| 2025-05-02 holding as of filing | Liddy Anne M. Officer (General Counsel) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $68.35 exercise price | 2025-05-02 | ||
| 2025-05-02 holding as of filing | Liddy Anne M. Officer (General Counsel) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $71.13 exercise price | 2025-05-02 | ||
| 2025-05-02 holding as of filing | Liddy Anne M. Officer (General Counsel) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $74.35 exercise price | 2025-05-02 | ||
| 2025-05-02 holding as of filing | Liddy Anne M. Officer (General Counsel) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $71.94 exercise price | 2025-05-02 | ||
| 2025-05-02 holding as of filing | Liddy Anne M. Officer (General Counsel) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $79.39 exercise price | 2025-05-02 | ||
| 2025-05-02 holding as of filing | Liddy Anne M. Officer (General Counsel) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $63.39 exercise price | 2025-05-02 | ||
| 2025-04-07 | McMillan Wayde D. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,171 5,171 owned after | $61.27 exercise price | 2025-04-09 | |
| 2025-02-26 | Wendell Amy McBride Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,535 5,535 owned after | $64.36 exercise price | 2025-02-28 | |
| 2025-02-26 | Stewart Stacey D. Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,535 5,535 owned after | $64.36 exercise price | 2025-02-28 | |
| 2025-02-26 | Stamoulis Christiana Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,535 5,535 owned after | $64.36 exercise price | 2025-02-28 | |
| 2025-02-26 | Mohtashami Nanaz Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,535 5,535 owned after | $64.36 exercise price | 2025-02-28 | |
| 2025-02-26 | Madaus Martin D Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,535 5,535 owned after | $64.36 exercise price | 2025-02-28 | |
| 2025-02-26 | HANTSON LUDWIG Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,535 5,535 owned after | $64.36 exercise price | 2025-02-28 | |
| 2025-02-26 | Dockendorff Charles J Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,535 5,535 owned after | $64.36 exercise price | 2025-02-28 | |
| 2025-02-10 | Horvath Mark W. Officer (Div. Pres., Breast & Skeletal) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,844 2,844 owned after | $65.24 exercise price | 2025-02-12 | |
| 2025-01-24 holding as of filing | Horvath Mark W. Officer (Div. Pres., Breast & Skeletal) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $66.35 exercise price | 2025-01-24 | ||
| 2025-01-24 holding as of filing | Horvath Mark W. Officer (Div. Pres., Breast & Skeletal) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $71.13 exercise price | 2025-01-24 | ||
| 2025-01-24 holding as of filing | Horvath Mark W. Officer (Div. Pres., Breast & Skeletal) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $74.35 exercise price | 2025-01-24 | ||
| 2025-01-24 holding as of filing | Horvath Mark W. Officer (Div. Pres., Breast & Skeletal) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $71.94 exercise price | 2025-01-24 | ||
| 2025-01-24 holding as of filing | Horvath Mark W. Officer (Div. Pres., Breast & Skeletal) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $79.39 exercise price | 2025-01-24 |